Robert Earle Grove - 14 Jun 2023 Form 4 Insider Report for IRIDEX CORP (IRIX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
15 Jun 2023, 18:57:42 UTC
Prior SEC filing
16 Jun 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Nilo De Castro, Attorney-in-fact for Robert Earle Grove

Key filing fact

Robert Earle Grove filed Form 4 for IRIDEX CORP (IRIX) on 15 Jun 2023.

Key facts

  • This page summarizes Robert Earle Grove's Form 4 filing for IRIDEX CORP (IRIX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 15 Jun 2023, 18:57.

Change

  • Previous filing in this sequence was filed on 16 Jun 2022.
  • Current net transaction value: +$75,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IRIX transaction

Common Stock

Award

Transaction value
$75,000
Shares
+39,267
Change %
+32%
Price
$1.91
Shares after
160,103
Date
14 Jun 2023
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. 100% of the RSUs vest on the earlier of June 14, 2024 or the date of the Issuer's next annual meeting of stockholders.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .